The California Plasma Coalition (CalPlasma) today launched a statewide campaign to raise awareness of the vital role that plasma donations play in saving lives of Californians and patients around the ...

“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

Richard Geary; Executive Vice President, Chief Development Officer; Ionis Pharmaceuticals Inc Elizabeth Hougen; Chief Financial Officer, Executive Vice President - Finance; Ionis Pharmaceuticals Inc ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

A series of injectable and oral treatments that require chronic dosing are already available ... but frequently do not eliminate all, angioedema attacks and require lifelong administration.

Ionis Pharmaceuticals IONS incurred a loss of 66 cents per share for fourth-quarter 2024, which was narrower than the Zacks ...

In a recent conference call to discuss its 2024 Q4 financial results, Ionis Pharmaceuticals highlighted its transition into a ...

A panelist discusses how their institution implements robust safety protocols including distinct labeling, electronic health record alerts, and staff education to prevent dispensing errors when ...

Fibrosis has a key role in the progression of kidney disease and kidney failure. Here, the authors examine current options for targeting pro-fibrotic pathways, including the anti-fibrotic ...